Fatigue in patients with multiple sclerosis. Multiple sclerosis
Conditions
Interventions
Intervention 1: Intervention group: Patients in the intervention group are given Famperidine (Delfyra 10 mg ) (from Cinnagen Pharmaceutical Company) twice daily for three months. Intervention 2: Contr
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with MS over the age of 18 who have not taken Dalfyra for the past year. Patients have The Expanded Disability Status Scale (EDSS) below 7
Exclusion criteria
Exclusion criteria: Patients have a kidney problem or a history of seizures. Patients who are allergic to this drug. Patients who have had an acute attack in the last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue score based on modified fatigue impact scale (MFIS) questionnaire. Timepoint: Both groups complete the Fatigue score based on modified fatigue impact scale (MFIS) questionnaire at the beginning of the study and three months later. Method of measurement: Based on the Fatigue score based on modified fatigue impact scale (MFIS) questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShirin Mavandadi
Qazvin University of Medical Sciences
Outcome results
None listed